Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma

Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma

US Patent 5910505 · Granted Jun 8, 1999

Estimated economic value: $216,914,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyridyloxypyrazole compounds2017
AKT inhibitors2013
Triazolyl aminopyrimidine compounds2012
Triazolyl aminopyrimidine compounds2011
Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer2011
Quinolinyl-pyrrolopyrazoles2010
TGF-β inhibitors2009
Mixed lineage kinase modulators2009
Compounds as pharmaceutical agents2008
Pyrazolopyridine derivatives as pharmaceutical agents2008
Quinolinyl-pyrrolopyrazoles2007
Cyclopenta[b]indole derivatives as sPLA2 inhibitors2007